517 related articles for article (PubMed ID: 27241179)
1. Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases.
Momtazi AA; Derosa G; Maffioli P; Banach M; Sahebkar A
Mol Diagn Ther; 2016 Aug; 20(4):335-45. PubMed ID: 27241179
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms underlying curcumin-mediated microRNA regulation in carcinogenesis; Focused on gastrointestinal cancers.
Akbari A; Sedaghat M; Heshmati J; Tabaeian SP; Dehghani S; Pizarro AB; Rostami Z; Agah S
Biomed Pharmacother; 2021 Sep; 141():111849. PubMed ID: 34214729
[TBL] [Abstract][Full Text] [Related]
3. The targeting of non‑coding RNAs by curcumin: Facts and hopes for cancer therapy (Review).
Liu Y; Sun H; Makabel B; Cui Q; Li J; Su C; Ashby CR; Chen Z; Zhang J
Oncol Rep; 2019 Jul; 42(1):20-34. PubMed ID: 31059075
[TBL] [Abstract][Full Text] [Related]
4. Curcumin and endometriosis: Review on potential roles and molecular mechanisms.
Arablou T; Kolahdouz-Mohammadi R
Biomed Pharmacother; 2018 Jan; 97():91-97. PubMed ID: 29080464
[TBL] [Abstract][Full Text] [Related]
5. Curcumin as a potential protective compound against cardiac diseases.
Jiang S; Han J; Li T; Xin Z; Ma Z; Di W; Hu W; Gong B; Di S; Wang D; Yang Y
Pharmacol Res; 2017 May; 119():373-383. PubMed ID: 28274852
[TBL] [Abstract][Full Text] [Related]
6. Curcumin as a natural regulator of monocyte chemoattractant protein-1.
Karimian MS; Pirro M; Majeed M; Sahebkar A
Cytokine Growth Factor Rev; 2017 Feb; 33():55-63. PubMed ID: 27743775
[TBL] [Abstract][Full Text] [Related]
7. Curcumin: a Polyphenol with Molecular Targets for Cancer Control.
Qadir MI; Naqvi ST; Muhammad SA
Asian Pac J Cancer Prev; 2016; 17(6):2735-9. PubMed ID: 27356682
[TBL] [Abstract][Full Text] [Related]
8. Curcumin: therapeutical potential in ophthalmology.
Pescosolido N; Giannotti R; Plateroti AM; Pascarella A; Nebbioso M
Planta Med; 2014 Mar; 80(4):249-54. PubMed ID: 24323538
[TBL] [Abstract][Full Text] [Related]
9. A review of therapeutic effects of curcumin.
Noorafshan A; Ashkani-Esfahani S
Curr Pharm Des; 2013; 19(11):2032-46. PubMed ID: 23116311
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and Pharmacodynamics of Curcumin in regulating anti-inflammatory and epigenetic gene expression.
Boyanapalli SSS; Huang Y; Su Z; Cheng D; Zhang C; Guo Y; Rao R; Androulakis IP; Kong AN
Biopharm Drug Dispos; 2018 Jun; 39(6):289-297. PubMed ID: 29870054
[TBL] [Abstract][Full Text] [Related]
11. Curcuma longa and curcumin affect respiratory and allergic disorders, experimental and clinical evidence: A comprehensive and updated review.
Memarzia A; Saadat S; Behrouz S; Boskabady MH
Biofactors; 2022 May; 48(3):521-551. PubMed ID: 34932258
[TBL] [Abstract][Full Text] [Related]
12. New Promising Therapeutic Avenues of Curcumin in Brain Diseases.
Benameur T; Giacomucci G; Panaro MA; Ruggiero M; Trotta T; Monda V; Pizzolorusso I; Lofrumento DD; Porro C; Messina G
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011468
[TBL] [Abstract][Full Text] [Related]
13. Sensing the scent of death: Modulation of microRNAs by Curcumin in gastrointestinal cancers.
Ashrafizadeh M; Zarrabi A; Hashemipour M; Vosough M; Najafi M; Shahinozzaman M; Hushmandi K; Khan H; Mirzaei H
Pharmacol Res; 2020 Oct; 160():105199. PubMed ID: 32942019
[TBL] [Abstract][Full Text] [Related]
14. Curcumin as a MicroRNA Regulator in Cancer: A Review.
Momtazi AA; Shahabipour F; Khatibi S; Johnston TP; Pirro M; Sahebkar A
Rev Physiol Biochem Pharmacol; 2016; 171():1-38. PubMed ID: 27457236
[TBL] [Abstract][Full Text] [Related]
15. Effects of curcumin on HDL functionality.
Ganjali S; Blesso CN; Banach M; Pirro M; Majeed M; Sahebkar A
Pharmacol Res; 2017 May; 119():208-218. PubMed ID: 28192240
[TBL] [Abstract][Full Text] [Related]
16. Transformation of curcumin from food additive to multifunctional medicine: nanotechnology bridging the gap.
Ahmad MZ; Akhter S; Mohsin N; Abdel-Wahab BA; Ahmad J; Warsi MH; Rahman M; Mallick N; Ahmad FJ
Curr Drug Discov Technol; 2014; 11(3):197-213. PubMed ID: 24934264
[TBL] [Abstract][Full Text] [Related]
17. Cellular and Molecular Mechanisms of Curcumin in Thyroid Gland Disorders.
Shakeri F; Bibak B; Safdari MR; Keshavarzi Z; Jamialahmadi T; Sathyapalan T; Sahebkar A
Curr Med Chem; 2022; 29(16):2878-2890. PubMed ID: 35142266
[TBL] [Abstract][Full Text] [Related]
18. Biological and pharmacological evaluation of dimethoxycurcumin: A metabolically stable curcumin analogue with a promising therapeutic potential.
Teymouri M; Barati N; Pirro M; Sahebkar A
J Cell Physiol; 2018 Jan; 233(1):124-140. PubMed ID: 27996095
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant and anti-inflammatory properties of curcumin.
Menon VP; Sudheer AR
Adv Exp Med Biol; 2007; 595():105-25. PubMed ID: 17569207
[TBL] [Abstract][Full Text] [Related]
20. Curcumin for neuropsychiatric disorders: a review of in vitro, animal and human studies.
Lopresti AL
J Psychopharmacol; 2017 Mar; 31(3):287-302. PubMed ID: 28135888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
